What was Guided Therapeutics Inc’s price range in the past 12 months?
Guided Therapeutics Inc lowest stock price was $0.06 and its highest was $0.30 in the past 12 months.
What is Guided Therapeutics Inc’s market cap?
Currently, no data Available
When is Guided Therapeutics Inc’s upcoming earnings report date?
Guided Therapeutics Inc’s upcoming earnings report date is Nov 13, 2023 which is 162 days ago.
How were Guided Therapeutics Inc’s earnings last quarter?
Guided Therapeutics Inc released its earnings results on Aug 15, 2023. The company reported -$0.032 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.032.
Guided Therapeutics Inc does not currently pay dividends.
What is Guided Therapeutics Inc’s EPS estimate?
Guided Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Guided Therapeutics Inc have?
Guided Therapeutics Inc has 55,613,450 shares outstanding.
What happened to Guided Therapeutics Inc’s price movement after its last earnings report?
Guided Therapeutics Inc reported an EPS of -$0.032 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Guided Therapeutics Inc?
Currently, no hedge funds are holding shares in GTHP
Guided Therapeutics, Inc. enagges in the development of medical devices. It focuses on the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. The company was founded by Shabbir Bakir Bambot, Mark L. Faupel, and Richard L. Fowler on October 27, 1992 and is headquartered in Norcross, GA.